Roche Buys Ignyta for $1.7B; Mallinckrodt to Pay $1.2B for Sucampo and More...
 Trouble viewing this email? Read it online
Follow us on:       
Sponsored by Jubilant
December 27, 2017
Magazine  I  News  I  Research  I  Directory  I  Topics  I  Classifieds  I  Resources  I  Provider Microsites
Sponsored by Thermo Fisher

FEATURED NEWS
Roche to Acquire Ignyta in $1.7B Deal
Expands oncology portfolio globally
Read More >>

Mallinckrodt to Pay $1.2B for Sucampo Pharmaceuticals
The deal includes all of Sucampo's commercial and development assets
Read More >>

Compliance with New USP Regulations on Elemental Impurities
USP <232> and <233> go into effect soon. With high sensitivity, low running costs, and easy-to-use software, Shimadzu ICP mass spectrometer is the optimum solution for analysis of toxic elements.
Learn More >>

LATEST STORIES
PixarBio, Particle Sciences Enter Manufacturing Agreement
For 14-day post-surgical pain treatment
Read More >>

Xspray, NerPharMa Sign Manufacturing and Supply Agreement
For the clinical and world-wide commercial supply of HyNap-Dasa
Read More >>

Juno, Thermo Fisher Announce CAR T Manufacturing Partnership
The partnership is in the form of a seven-year nonexclusive licensing and supply agreement
Read More >>

Crown Bioscience Announces Merger with JSR Corporation
The company will become a fully owned subsidiary of JSR Corporation
Read More >>

Otsuka, X-Chem Partner for Drug Discovery
X-Chem will utilize its DNA-encoded library to search for novel drug leads for several Otsuka discovery targets
Read More >>

TRACON and Ambrx Enter Development Agreement
The partnership resolves around the commercialization and development of TRC105 (carotuximab) in China
Read More >>

Janssen, Legend Partner for Multiple Myeloma
To develop, manufacture and commercialize a chimeric antigen receptor CAR T-cell drug candidate, LCAR-B38M
Read More >>

Summit, Eurofarma Labs Enter License Agreement
Eurofarma gains exclusive license to CDI precision antibiotic in Latin America
Read More >>

   

CURRENT ISSUE
November/December 2017



Whitepaper Spotlight

Serialization: Optimizing Planning and Implementation
Released by: Recro Gainesville
Download this White Paper to learn more about how an outsourcing partner like Recro Gainseville can deliver efficient serialization solutions.


Microsite Spotlight

Vetter is a leading contract development and manufacturing organization (CDMO) that specializes in the aseptic filling of syringes, cartridges and vials.


We hope you enjoyed this edition of Contract Pharma Direct's Breaking News

You are receiving this message because you opted in at contractpharma.com. To change your preferences or unsubscribe please use the links below.

To ensure delivery and proper display of your emails, please add our email address (cp@email.contractpharma.com) to your address book and if needed enable images in your email client.

To update your user profile please click here.

To unsubscribe or change your email subscription preferences please click here.

If you are having trouble with receiving Contract Pharma Magazine or would like to receive it, click here.

Advertise with us

Our mailing address is:

Contract Pharma
Rodman Media
70 Hilltop Road, Ramsey, NJ 07446 USA
Tel: 201-825-2552, Fax: 201-825-0553

© Copyright 2017 Contract Pharma All rights reserved.